BRÈVE

sur Pathcore Inc.

Pathcore Announces Strategic Partnership With Instem to Enhance Digital Pathology Solutions

TORONTO, ON / ACCESSWIRE / June 13, 2024 / Pathcore Inc., a leader in digital pathology software solutions, has announced a strategic partnership with Instem, a provider of IT solutions to the global life sciences market. Representatives from both companies will be at Booth 200 during the upcoming 43rd Annual Symposium of the Society of Toxicologic Pathology from June 19-24, 2024, in Baltimore, MD.

This collaboration will allow the integration of Instem’s Provantis® preclinical data management solution and Pathcore’s PathcoreFlow image management system. The automatic exchange of study data between these platforms will eliminate manual data entry, enabling toxicologic pathologists to perform digital primary reads more efficiently. This integration aims to speed up reporting and improve accuracy in one of the most complex anatomic pathology subspecialties.

The combined solution will be GLP-compliant and meet FDA requirements for preclinical studies. "We are thrilled to partner with Instem to bring this advanced solution to market," said Dan Hosseinzadeh, co-founder and CEO at Pathcore.

This partnership represents a significant advancement in digital pathology for pre-clinical toxicopathology studies, making workflows more streamlined and data management more robust.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Pathcore Inc.